Impact of Covid19 Lockdown on Glycemic Control
Rodriguez G, Bahtiyar M, Kirupakaran J, Kubbar A, Singh S, Karnik S, Hashmi S, Bahtiyar G. Impact of Covid19 Lockdown on Glycemic Control. Journal Of The Endocrine Society 2021, 5: a345-a345. PMCID: PMC8135324, DOI: 10.1210/jendso/bvab048.703.Peer-Reviewed Original ResearchGlycemic controlGlucose controlRetrospective cohort studyIntensive insulin therapyPoor glycemic controlGood glycemic controlType 2 diabetesCohort studyEndocrine clinicInsulin therapyMean ageCommunity hospitalContinuous glucose monitoring dataDiabetes managementType 2Glucose monitoring dataR. EffectsGreater riskType 1Lockdown phaseEffect of lockdownBMIDiabetesPatientsAfrican AmericansObesity and Covid-19: A Major Mortality Risk in Patients Hospitalized With Covid-19
Rodriguez G, Kim E, Cabezas F, Dave P, Li J, Kirupakaran J, Caputo M, Idowu A, Deane K, Tapia N, Korson M, Nunez D, Okaikoi M, Rodriguez P, Valentine D, Yau A, Zheng B, Aye T, Jimenez M, Elayaperumal P, Afzal A, Daruwala O, Williams B, Karnik S, Filias F, Inoue T, Asif H, Singh G, Kubbar A, Iwuala S, Zeyneloglu N, Bahtiyar M, Bahtiyar G. Obesity and Covid-19: A Major Mortality Risk in Patients Hospitalized With Covid-19. Journal Of The Endocrine Society 2021, 5: a53-a53. PMCID: PMC8089692, DOI: 10.1210/jendso/bvab048.106.Peer-Reviewed Original ResearchMortality rateCOVID-19Retrospective cohort studyChronic kidney diseaseHistory of diabetesCoronary artery diseaseCOVID-19 severityMajor public health crisisType 2 diabetesBMI 30Diabetic ketoacidosisMacrovascular diseaseMean HbA1cPublic health crisisSignificant comorbiditiesCohort studyArtery diseaseMajor mortality riskMultivariable analysisNormal weightKidney diseaseMean ageRisk factorsUnivariate analysisCommunity hospital